作为 MALAT1 RNA 三重螺旋插入因子的 N-融合喹唑啉二酮的无金属合成。

IF 3.597 Q2 Pharmacology, Toxicology and Pharmaceutics MedChemComm Pub Date : 2024-10-22 DOI:10.1039/D4MD00614C
Vijay Babu Pathi, Pranotosh Das, Abhyuday Guin, Manish Debnath and Biswadip Banerji
{"title":"作为 MALAT1 RNA 三重螺旋插入因子的 N-融合喹唑啉二酮的无金属合成。","authors":"Vijay Babu Pathi, Pranotosh Das, Abhyuday Guin, Manish Debnath and Biswadip Banerji","doi":"10.1039/D4MD00614C","DOIUrl":null,"url":null,"abstract":"<p >The development of chemical scaffolds that target highly conserved <em>MALAT1</em> RNA received attention due to its significance in splicing, nuclear organization, and gene expression in disease progression pathways. Here, we synthesized a series of N-fused quinazolino-quinazoline-diones <em>via</em> a PIDA-induced C–N coupling methodology to target <em>MALAT1</em>. Interestingly, compound <strong>2z</strong> binds to the UUG pocket of a <em>MALAT1</em> RNA triple-helix through intercalation, evidenced from molecular docking studies, fluorescence-based assay and CD experiments. <strong>2z</strong> exhibited cytotoxicity towards <em>MALAT1</em> overexpressing cancer cells (SKOV-3, IC<small><sub>50</sub></small> of 8.0 ± 0.4 μM). These findings demonstrated <strong>2z</strong> as a <em>MALAT1</em> RNA triple-helix intercalator with therapeutic potential, offering an important chemical scaffold to understand <em>MALAT1</em> activity in disease development pathways.</p>","PeriodicalId":88,"journal":{"name":"MedChemComm","volume":" 1","pages":" 429-434"},"PeriodicalIF":3.5970,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Metal-free synthesis of N-fused quinazolino-quinazoline-diones as a MALAT1 RNA triple helix intercalator†\",\"authors\":\"Vijay Babu Pathi, Pranotosh Das, Abhyuday Guin, Manish Debnath and Biswadip Banerji\",\"doi\":\"10.1039/D4MD00614C\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >The development of chemical scaffolds that target highly conserved <em>MALAT1</em> RNA received attention due to its significance in splicing, nuclear organization, and gene expression in disease progression pathways. Here, we synthesized a series of N-fused quinazolino-quinazoline-diones <em>via</em> a PIDA-induced C–N coupling methodology to target <em>MALAT1</em>. Interestingly, compound <strong>2z</strong> binds to the UUG pocket of a <em>MALAT1</em> RNA triple-helix through intercalation, evidenced from molecular docking studies, fluorescence-based assay and CD experiments. <strong>2z</strong> exhibited cytotoxicity towards <em>MALAT1</em> overexpressing cancer cells (SKOV-3, IC<small><sub>50</sub></small> of 8.0 ± 0.4 μM). These findings demonstrated <strong>2z</strong> as a <em>MALAT1</em> RNA triple-helix intercalator with therapeutic potential, offering an important chemical scaffold to understand <em>MALAT1</em> activity in disease development pathways.</p>\",\"PeriodicalId\":88,\"journal\":{\"name\":\"MedChemComm\",\"volume\":\" 1\",\"pages\":\" 429-434\"},\"PeriodicalIF\":3.5970,\"publicationDate\":\"2024-10-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MedChemComm\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2025/md/d4md00614c\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedChemComm","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/md/d4md00614c","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

由于 MALAT1 RNA 在疾病进展途径中的剪接、核组织和基因表达等方面的重要作用,针对高度保守的 MALAT1 RNA 的化学支架的开发受到了关注。在此,我们通过 PIDA 诱导的 C-N 偶联方法合成了一系列 N-融合喹唑啉-喹唑啉二酮,以 MALAT1 为靶标。有趣的是,化合物 2z 通过插层结合到了 MALAT1 RNA 三重螺旋的 UUG 口袋中,分子对接研究、荧光检测和 CD 实验都证明了这一点。2z 对过度表达 MALAT1 的癌细胞(SKOV-3,IC50 为 8.0 ± 0.4 μM)具有细胞毒性。这些研究结果表明,2z 是一种具有治疗潜力的 MALAT1 RNA 三重螺旋插入物,为了解 MALAT1 在疾病发展途径中的活性提供了一个重要的化学支架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Metal-free synthesis of N-fused quinazolino-quinazoline-diones as a MALAT1 RNA triple helix intercalator†

The development of chemical scaffolds that target highly conserved MALAT1 RNA received attention due to its significance in splicing, nuclear organization, and gene expression in disease progression pathways. Here, we synthesized a series of N-fused quinazolino-quinazoline-diones via a PIDA-induced C–N coupling methodology to target MALAT1. Interestingly, compound 2z binds to the UUG pocket of a MALAT1 RNA triple-helix through intercalation, evidenced from molecular docking studies, fluorescence-based assay and CD experiments. 2z exhibited cytotoxicity towards MALAT1 overexpressing cancer cells (SKOV-3, IC50 of 8.0 ± 0.4 μM). These findings demonstrated 2z as a MALAT1 RNA triple-helix intercalator with therapeutic potential, offering an important chemical scaffold to understand MALAT1 activity in disease development pathways.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
MedChemComm
MedChemComm BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL
CiteScore
4.70
自引率
0.00%
发文量
0
审稿时长
2.2 months
期刊介绍: Research and review articles in medicinal chemistry and related drug discovery science; the official journal of the European Federation for Medicinal Chemistry. In 2020, MedChemComm will change its name to RSC Medicinal Chemistry. Issue 12, 2019 will be the last issue as MedChemComm.
期刊最新文献
Back cover Correction: Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy Back cover 2-(4-Bromobenzyl) tethered 4-amino aryl/alkyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines: design, synthesis, anticancer assessment via dual topoisomerase-I/II inhibition, and in silico studies† Back cover
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1